Financials
- Market Capitalization 1.49 B
- Employee 77
- Founded 2021
- CEO N/A
- Website www.arrivent.com
- Headquarter Delaware, United States
- FIGI BBG011N37VQ0
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2188 | ABSI Absci Corporation - Common Stock | 8.72 USD | -7.43% | -8.69% | +23.16% | +253.04% | 1.50 B USD | ||
| 2196 | REPL Replimune Group, Inc. - Common Stock | 15.50 USD | -0.64% | +4.94% | +195.24% | +189.18% | 1.46 B USD | ||
| 2202 | NVAX Novavax, Inc. - Common Stock | 9.27 USD | +2.43% | +3.69% | +27.16% | +22.62% | 1.53 B USD | ||
| 2237 | CGEM Cullinan Therapeutics, Inc. - Common Stock | 21.72 USD | -3.89% | +0.18% | +23.06% | +183.92% | 1.40 B USD |
Frequently asked questions about ArriVent BioPharma, Inc. Common Stock
What is the ArriVent BioPharma, Inc. Common Stock stock price today?
The current price of ArriVent BioPharma, Inc. Common Stock (AVBP) is 30.21. Over the past 24 hours, the stock has changed by -2.55%. Follow the AVBP chart for real-time price dynamics.
What is the stock ticker of ArriVent BioPharma, Inc. Common Stock?
ArriVent BioPharma, Inc. Common Stock trades under the ticker AVBP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is ArriVent BioPharma, Inc. Common Stock stock going up?
AVBP has changed by +3.74% over the last week, +0.94% over the last month, and +57.51% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of ArriVent BioPharma, Inc. Common Stock?
ArriVent BioPharma, Inc. Common Stock currently has a market capitalization of 1.49 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were ArriVent BioPharma, Inc. Common Stock earnings last quarter?
Last quarter, ArriVent BioPharma, Inc. Common Stock reported earnings of -1.05 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was ArriVent BioPharma, Inc. Common Stock net income for the last quarter?
ArriVent BioPharma, Inc. Common Stock reported net income of -49.89 M for the last quarter. The previous quarter showed -43.32 M, which means net income changed by -15.17%.
How many employees does ArriVent BioPharma, Inc. Common Stock have?
As of the latest available data, ArriVent BioPharma, Inc. Common Stock has 77 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy ArriVent BioPharma, Inc. Common Stock stock?
You can buy ArriVent BioPharma, Inc. Common Stock (AVBP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in ArriVent BioPharma, Inc. Common Stock stock?
Investing in ArriVent BioPharma, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the AVBP chart and related analysis on metatrader.com as part of your research.